Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on September 9, 2025
The Brookbush Institute Publishes a NEW Glossary Term: 'Retrospective Study'
The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- - Excerpt from Glossary Term: Retrospective …
Redefining Healthcare Access: EasyCare2go Expands Hybrid Virtual Healthcare With Bundled Membership Model
EasyCare2go Launches a Subscription-Based Healthcare Membership Program Combining Virtual Care, In-Person Services, Emotional Care, and Bundled Hygiene Benefits NY, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- EasyCare2go, founded by Dr. Clive …
KFSHRC Deputy CEO at C3 Davos of Healthcare™ Summit: AI Will Support, Not Replace, Healthcare Workers
NY, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- Artificial intelligence is ready to play a major role in healthcare, but it must be seen as a tool to empower medical staff, not replace them, according to Dr. Björn Zoëga, Deputy CEO of King …
Vexos Appoints New SVP of Operational Excellence; and Expands Juarez Manufacturing Capacity
NEW YORK, NY, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- Vexos, a leading global electronics manufacturing services (EMS) and custom material solutions (CMS) provider, is proud to announce the appointment of Hadi Farashahi as Senior Vice …
MA Asset Management and KeyBank Provide $175MM Financing to Drive HFD Platform Expansion
The transaction highlights MA Asset Management’s continued expansion into high-growth sectors of U.S. private credit. NEW YORK, NY, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- Private credit investment manager MA Asset Management, via its …
New Book Unites Oncology’s Brightest Minds to Innovate Cancer Cures
“Voices of Oncology” by Kirk V. Shepard, M.D., and Ramin Farhood, PharmD, M.B.A., is released with Forbes Books. NEW YORK, NY, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- “Voices of Oncology: Fostering a Collaborative Community of Experts to …
Mindfulness Meets Healthcare Policy in a Transformational New Book
“The Zen Lobbyist: A Mindful Approach to Transforming Healthcare” by Gary Jacobs is released with Forbes Books. NEW YORK, NY, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- "The Zen Lobbyist: A Mindful Approach to Transforming Healthcare" by …
Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for …
Significant Breakthrough! eefit Far Infrared Technology Improves Two Major Symptoms of Alzheimer’s Disease, Bringing New Hope to Brain Health Protection
Hong Kong, Sept. 09, 2025 (GLOBE NEWSWIRE) -- With Hong Kong’s aging population, Alzheimer’s disease has become a major public health challenge. The Hong Kong Council of Social Service projects that by 2036, the number of people with dementia in Hong Kong …
University Hospital Foundation announces project to support Alberta dementia patients and their families
Edmonton, AB, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The University Hospital Foundation is proud to launch the Dementia Care Pathways Project, a bold initiative aimed at transforming how we diagnose and support Albertans living with dementia in our communities …
Actuate Therapeutics Announces Proposed Public Offering of Common Stock
CHICAGO and FORT WORTH, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult …
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
MOUNTAIN VIEW, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar’s Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- OptimizeRx (the “Company”) …
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025
DENVER, Sept. 09, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All- …
Picard Medical, Inc. Announces Exercise of Underwriters’ Over-Allotment Option in Connection with its Initial Public Offering
TUCSON, Ariz., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that the underwriters of its previously announced initial public offering of common stock, par value $0.0001 per share …
Celcuity Announces Upsized Senior Secured Term Loan Facility of $500 Million with Innovatus Capital Partners and Oxford Finance
MINNEAPOLIS, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (“Celcuity”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it has entered into an amendment to its existing senior secured …
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
ZUG, Switzerland and BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that a late-breaking oral …
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
Transaction structured to provide flexible funding to support Phase 1b registrational clinical study program in advanced Parkinson’s under the 505(b)(2) NDA pathway Evaluating complementary funding including strategic equity and non-dilutive alternatives …